Pelvic congestion syndrome (PCS) is treated with a combination of lifestyle changes, hormonal medications, and minimally invasive procedures that close off the enlarged veins causing pain. About 75% of women who undergo the most common procedure, vein embolization, experience substantial pain relief. Treatment typically starts conservatively and escalates based on how you respond.
PCS accounts for roughly 30% of chronic pelvic pain cases in women. It develops when veins around the uterus and ovaries become dilated and engorged, similar to varicose veins in the legs. Veins wider than 5 mm on ultrasound are a key diagnostic marker, with predictive accuracy improving at 6 mm or above. Once diagnosed, the goal of treatment is to reduce blood pooling in these veins, either by shrinking them with medication or sealing them off with a procedure.
Lifestyle Changes as a Starting Point
The Society for Vascular Surgery recommends beginning with lifestyle modifications before moving to medications or procedures. Avoiding prolonged standing and sitting helps reduce venous pressure in the pelvis. Weight loss, when applicable, also decreases the load on pelvic veins. Posture adjustments and gentle exercise that improves blood flow, such as walking or specific pelvic floor movements, can complement these changes.
A pelvic health physical therapist can evaluate your posture, pelvic floor muscle activity, and daily habits, then design an exercise program aimed at improving venous return from the pelvis. These strategies rarely resolve PCS on their own, but they can reduce symptom severity and work alongside other treatments.
Hormonal Medications
Hormonal therapy targets the underlying mechanism of PCS by suppressing ovarian function, which causes the dilated veins to contract and shrink. Two main hormonal options have been studied.
Medroxyprogesterone acetate (a synthetic progesterone) is typically prescribed at 30 mg per day for four to six months. An injectable form given every three months is also used. In a study of 47 women, this approach reduced symptoms in about 65% of patients over a 12-month follow-up period.
A stronger option is a class of drugs called GnRH agonists (such as goserelin), which more aggressively suppress ovarian hormone production. Goserelin is given as a monthly injection for six months. In the same study comparing both treatments, goserelin proved superior to medroxyprogesterone for improving pelvic pain scores. The trade-off is that GnRH agonists essentially create a temporary menopause, bringing side effects like hot flashes, bone density loss, and mood changes, which limits how long you can stay on them.
Flavonoid Supplements
A plant-derived compound called micronized purified flavonoid fraction, commonly used for varicose veins in the legs, has also been studied for PCS. The typical regimen is 500 mg twice daily for six months. Some protocols use higher doses of 1,000 to 2,000 mg per day for eight weeks. This supplement strengthens vein walls and reduces inflammation, though evidence for PCS specifically is more limited than for hormonal therapy.
Vein Embolization: The Primary Procedure
When lifestyle changes and medications don’t provide enough relief, embolization is the most widely used next step. It’s a minimally invasive procedure performed through a small catheter, usually inserted through a vein in the neck or groin. The interventional radiologist guides the catheter to the enlarged pelvic veins and seals them using tiny metal coils, a special glue, or a chemical irritant (sclerosant). The blocked veins eventually scar shut, and blood reroutes through healthy veins.
A systematic review covering 1,308 women across 21 studies found that approximately 75% experienced substantial pain relief early after embolization, with improvement generally increasing over time and holding steady long-term. Pain measured on standardized scales dropped significantly in every study that tracked it. Repeat intervention rates were generally low.
That said, roughly one in three women may not feel meaningful relief. A separate analysis found complete or partial symptom improvement in 68% of patients, with 32% reporting no substantial benefit. This gap highlights why accurate diagnosis matters: pelvic pain often has multiple overlapping causes, and embolization only addresses the venous component.
Risks of Embolization
Embolization is considered safe, but it carries real complications. A retrospective analysis of gonadal vein procedures found post-procedure syndrome (temporary pelvic pain, low-grade fever, and nausea as the body reacts to the sealed veins) in 22% of cases. Pelvic or calf vein blood clots occurred in 24%, and coil protrusion, where the metal coil shifts slightly from its intended position, happened in about 5% of cases. Most of these complications are manageable, but they’re worth understanding before consenting to the procedure.
Iliac Vein Stenting for Compression
Some women have PCS not just from refluxing ovarian veins but also from a narrowed iliac vein in the pelvis, a condition sometimes called May-Thurner syndrome when the left iliac vein is compressed by an overlying artery. When both problems coexist, stenting the compressed iliac vein can relieve the underlying obstruction that’s driving venous congestion.
In a study of 141 women with both iliac vein narrowing and ovarian vein reflux, 78% reported complete symptom resolution after iliac vein stenting alone, without needing separate embolization of the ovarian veins. The average follow-up was about 12 months. After stenting, you’ll typically take a blood thinner for at least 90 days. If follow-up imaging shows clot buildup on the stent, residual narrowing, or scar tissue inside the vein, anticoagulation continues longer.
This approach is only appropriate when imaging confirms significant iliac vein compression. It’s not a substitute for embolization in women whose congestion comes purely from ovarian vein reflux.
Surgery as a Last Resort
Hysterectomy (with or without removal of the ovaries) is sometimes considered when other treatments have failed, particularly in women who are done with childbearing. Removing the ovaries eliminates the hormonal stimulus that keeps pelvic veins dilated. However, comparative data between hysterectomy and embolization remains limited, and surgery carries significantly longer recovery time and higher risk than catheter-based procedures. Most treatment algorithms reserve surgery for cases where less invasive options haven’t worked.
Choosing the Right Treatment Sequence
Treatment for PCS works best when it follows a stepwise approach. Lifestyle modifications and pain management come first. If pain persists, hormonal therapy for several months is a reasonable trial, especially if you want to avoid a procedure. When medications fall short or symptoms are severe, embolization is the standard next step. Iliac vein stenting enters the picture only when imaging reveals a compressed pelvic vein contributing to the problem.
One important consideration: labeling pelvic pain as PCS alone can sometimes miss other contributing conditions like endometriosis, bladder disorders, or musculoskeletal problems. If you’ve had embolization or hormonal therapy without adequate relief, a broader evaluation of other pain sources may be more productive than repeating vein-focused treatments.